FLNA Insider Trading Activity and SEC Form 4 Filings
FLNA insider trading summary
Over the past 12 months, insiders at Filana Therapeutics, Inc. (FLNA) reported 3 open-market purchases worth $356K by 1 insider and no sales on SEC Form 4. Net insider buying was $356K.
Latest FLNA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 30, 2026 | Richard Barry | President & CEO | Buy | $92K (100,000 @ $0.92) |
| Sep 29, 2026 | Richard Barry | President & CEO | Buy | $186K (206,813 @ $0.90) |
| Sep 28, 2026 | Richard Barry | President & CEO | Buy | $78K (93,091 @ $0.84) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.